Sign in

CIK 0001557746

  • Non-accelerated filer
  • Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460571712
Phone
+1 484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-03-01 Shanler Stuart Chief Scientific Officer Grant or award · Restricted stock units +82,200 82,200
2019-02-01 Shanler Stuart Chief Scientific Officer Exercise or conversion +3,875 273,355
2019-02-01 Shanler Stuart Chief Scientific Officer Shares withheld for taxes −1,308 $6.96 $9K 272,047
2019-02-01 Shanler Stuart Chief Scientific Officer Exercise or conversion · Restricted Stock Units −3,875 11,625
2018-12-18 Shanler Stuart Chief Scientific Officer Exercise or conversion +1,450 269,892
2018-12-18 Shanler Stuart Chief Scientific Officer Shares withheld for taxes −412 $6.30 $3K 269,480
2018-12-18 Shanler Stuart Chief Scientific Officer Exercise or conversion · Restricted Stock Units −1,450 1,450
2018-12-15 Shanler Stuart Chief Scientific Officer Exercise or conversion +1,300 268,812
2018-12-15 Shanler Stuart Chief Scientific Officer Shares withheld for taxes −370 $7.31 $3K 268,442
2018-12-15 Shanler Stuart Chief Scientific Officer Exercise or conversion · Restricted Stock Units −1,300 2,600
2018-05-07 Shanler Stuart Chief Scientific Officer Exercise or conversion +5,200 268,992
2018-05-07 Shanler Stuart Chief Scientific Officer Shares withheld for taxes −1,480 $18.10 $27K 267,512
2018-05-07 Shanler Stuart Chief Scientific Officer Exercise or conversion · Restricted Stock Units −5,200 3,900
2018-02-01 Shanler Stuart Chief Scientific Officer Grant or award · Stock option (right to buy) +54,000 54,000
2018-02-01 Shanler Stuart Chief Scientific Officer Grant or award · Restricted stock units +15,500 15,500
2017-12-18 Shanler Stuart Chief Scientific Officer Exercise or conversion +1,450 264,233
2017-12-18 Shanler Stuart Chief Scientific Officer Shares withheld for taxes −441 $24.12 $11K 263,792
2017-12-18 Shanler Stuart Chief Scientific Officer Exercise or conversion · Restricted Stock Units −1,450 2,900
2017-12-15 Shanler Stuart Chief Scientific Officer Exercise or conversion +1,300 263,178
2017-12-15 Shanler Stuart Chief Scientific Officer Shares withheld for taxes −395 $24.23 $10K 262,783

Page 1 of 2 · 28 trades